During the past decade, Jin-Tae Kim conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jin-Tae Kim" are "Arterial Line" (4 trials), "Cerebral Blood Flow" (2 trials), "Sedation" (2 trials), "Acute Kidney Injury" (1 trials) and "Acute Pain" (1 trials). Many other conditions were trialed in "Jin-Tae Kim" in a lesser frequency.

Most popular intervention types in "Jin-Tae Kim" are "Drug" (7 trials), "Device" (6 trials), "Other" (5 trials), "Procedure" (5 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Control" (4 trials), "Intranasal dexmedetomidine and ketamine" (2 trials), "Nitroglycerin" (2 trials), "Normal saline" (2 trials) and "Oral chloral hydrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Jin-Tae Kim" are 25 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Jin-Tae Kim". 1 are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Jin-Tae Kim, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jin-Tae Kim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 20 trials that are defined as “Not Applicable".